A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B)

Clinical trial NCT05277571 · COMPLETED

Trial details

NCT number: NCT05277571
Sponsor: UCB Biopharma SRL
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2022-03-07
Primary completion: 2025-07-17
Enrollment: 109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.